Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil

Revista de Saude Publica

Volumn 42, Issue 3, 2008, Pages 443-449

  Huatuco, E M M ^a   Durigon, E L ^a   Lebrun, F L A S ^a   Passos, S D ^b   Gazeta, R E ^b   Neto, R S Azevedo ^a   Massad, Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE MEDICINA DE JUNDIAÍ   (Brazil)

Author keywords

Epidemiology; Human; Parvoviridae infections; Parvovirus B19; Risk groups; Seroepidemiologic studies

Indexed keywords

EID: 48749111915     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102008000300008     Document Type: Article

References (23)

1. Abarca K, Cohen BJ, Vial PA. Seroprevalence of Parvovirus B19 in urban Chilean children and young adults, 1990 and 1996. Epidemiol Infect. 2002;128(1):59-62.
2. Abraham M, Rudraraju R, Kannangai R, George K, Cherian T, Daniel D, Ramalingam R, Sridharan G. A pilot study on the seroprevalence of parvovirus B19 infection. Indian J Med Res. 2002;115:139-43.
3. Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tatersall P, Mortimer P. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986;24(4):522-6.
4. Brown KE. Human parvovirus B19 epidemiology and clinical manifestations. In: Anderson LJ, Young NS, editores. Human parvovirus B19. New York: Karger; 1997. p. 42-60. (Monographs in Virology, 20).
5. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993;262(5130):114-7.
6. Brown T, Anand A, Ritchie LD, Clewley Jr, Reid TM. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984;2(8410):1033-4.
7. Cochran WG. Sampling Techniques. 3. ed. New York: John Wiley & Sons; 1977.
8. Coutinho FAB, Massad E, Burattini MN, Yang HM, Azevedo Neto RS. Effects of vaccination programmes on transmission rates of infegfions and related threshold conditions for control. IMA J Math Appl Med Biol. 1993;10(3):187-206.
9. Deiss V, Tratschin JD, Weitz M, Siegl G. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology. 1990;175(1):247-54.
10. Foto F, Saag KC, Scharosch LL, Howard EJ, Naides SJ. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis. 1993;167(3):744-8.
11. Fundação Instituto Brasileiro de Geografia e Estatística. IX Recenseamento geral do Brasil:1980. Rio de Janeiro; 1983.
12. Gay NJ, Hesketh LM, Cohen BJ, Rush M, Bates C, Morgan-Capner P, et al. Age specific antibody prevalence to parvovirus B19: How many women are infected in pregnancy? Commun Dis Rep CDR Rev. 1994;4(9):R104-7.
13. Guerra ML, Prior C, Merino R, Zapico R. Seroprevalencia de parvovirus B19 en nuestra área y su distribucion por edades y sexos. Enferm Infecc Microbiol Clin. 2000;18(5):243-4.
14. Kajigaya S, Momoeda M. Immune response to B19 infection. In: Anderson LJ, Young NS, editores. Human parvovirus B19. Switzerland: Karger; 1997. p.120-36. (Monographs in Virology, 20).
15. Laub R, Strengers P. Parvovirus and blood products. Pathol Biol (Paris). 2002;50(5):339-48.
16. Massad E, Azevedo-Neto RS, Burattini MN, Zanetta DMT, Coutinho FAB, Yang HM, et al. Assessing the efficacy of a mixed vaccination strategy against rubella in São Paulo, Brazil. Int J Epidemiol. 1995;24(4):842-50.
17. Nascimento JP, Buckley M, Brown K, Cohen BJ. The prevalence of antibodies to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo. 1990;32(1):41-5.
18. Neto RSA, Silveira ASBS, Nokes DJ, Yang HM, Passos SD, Cardoso MRA, Massad E. Rubella seroepidemiology in a non-immunized population of São Paulo State, Brazil. Epidemiol. Infect. 1994; 113(1):161-73.
19. Neto RSA, Richard A, Nokes DJ, Silveira ASB, Cohen BJ, Passos SD, et al. Salivary antibody detection in epidemiological surveys: A pilot study after a mass vaccination campaing against rubella in São Paulo, Brazil. Trans R Soc Trop Med Hyg. 1995;89(1):115-8.
20. Rodis JF. Parvovirus infection. Clin Obstet Gynecol. 1999;42(1):107-20
21. Sodja I, Mrázová M, Smelhausová M, Kotrbová K, Pazdiora P, Bruj J, et al. Seroprevalence of IgG antibodies against parvovirus B19 in the Czech Republic. Epidemiol Mikrobiol Imunol. 1995;44(4):171-4.
22. Van Regenmortel MHV, Fauquet CM, Bishop DHL. Virus taxonomy: classification and nomenclature of viruses. In: Seventh report of the International Committee on Taxonomy of Viruses; San Diego, CA. San Diego: Academic Press; 2000.
23. Zanetta RAC, Amaku M, Azevedo RS, Zanetta DMT, Burattini MN, Massad E. Optimal ages for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother's serostatus. Vaccine. 2001;20(1-2):226-34.